Frontiers-Medicine

🌍 Today is World Digestive Health Day, a global initiative led by the World Gastroenterology Organisation (WGO), and there’s no better time to spotlight the science driving progress in gut health. At Frontiers in Gastroenterology, we’re proud to be part of this global conversation. We’ve just surpassed 200 published articles, covering the full breadth of gastroenterology research from inflammatory bowel disease and hepatology to microbiome science, endoscopy, and beyond. 🔬 To the researchers and clinicians pushing boundaries in digestive health: ✅ Explore our growing library of open-access articles at https://lnkd.in/eaU9PR3B ✅ Interested in submitting your research or collaborating? We’d love to hear from you, so please reach out directly by email: gastroenterology@frontiersin.org As a reminder, Frontiers in Gastroenterology is indexed in PubMed and PubMed Central, so your work is discoverable by the global research community from the moment it’s published. At Frontiers, your research is published open access, making it freely available to scientists, clinicians, and policymakers worldwide. A huge thank you to our Chief Editor, Colm O'Morain, and the entire editorial board for their dedication to advancing gastroenterology research. #WorldDigestiveHealthDay #Gastroenterology #OpenAccess #GutHealth #PubMed #Frontiers #DigestiveDiseases #GIResearch

📢 Frontiers in Urology | New Research Topic Now Open for Submissions Neurogenic Mechanisms Underlying Lower Urinary Tract Symptoms and Dysfunction Neurogenic lower urinary tract dysfunction (NLUTD) is a leading cause of morbidity, recurrent infections, upper tract damage, and reduced quality of life - affecting patients across a wide spectrum of neurological conditions, from spinal cord injury and multiple sclerosis to Parkinson’s disease, stroke, and diabetic neuropathy. Yet the mechanisms linking neural injury to specific bladder phenotypes remain incompletely understood. We welcome contributions on: 🔹 Central and peripheral neural circuit control of bladder storage and voiding 🔹 Neuroinflammation and neuroimmune interactions in the lower urinary tract 🔹 Detrusor overactivity, underactivity, and detrusor-sphincter dyssynergia 🔹 Neuromodulation therapies: sacral, pudendal, tibial, and transcutaneous nerve stimulation 🔹 Brain-bladder axis: neuroimaging and cortical regulation of micturition 🔹 Disease-specific mechanisms: Parkinson’s, MS, diabetic cystopathy, spina bifida 🔹 Emerging pharmacological, gene therapy, and regenerative approaches 📅 Submission deadline: 13 November 2026 📌 Published in Frontiers in Urology — section Neurourology, Behavioural Urology, and Urodynamics 👉 Submit your manuscript: https://lnkd.in/exc4dgvF #FrontiersInUrology #Neurourology #LUTS #NeurogenicBladder #Urology #Neuromodulation #BrainBladderAxis #OpenAccess #CallForPapers

🌟 Attending ERA 2026 in Glasgow? Come meet the Frontiers in Nephrology team! 🌟 We’re excited to be at the 63rd ERA Congress - the largest nephrology congress in Europe - taking place June 3–6, 2026 in Glasgow, Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Whether you’re a researcher, clinician, or educator working in kidney disease, this is one of the most important gatherings in our field and we’d love to connect with you in person. 🤝 Book a meeting with the Frontiers in Nephrology team to discuss: * Submitting your latest research * Launching or contributing to a Research Topic * Joining our editorial board * Open access publishing and our author support 📅 Reach out to us to schedule your slot on Wednesday 3rd: spaces are limited, so don’t wait! 👉 Drop us an email at nephrology@frontiersin.org We look forward to seeing you in Glasgow! 🧬💙 #ERA2026 #ERA26 #Nephrology #KidneyDisease #OpenAccess #FrontiersInNephrology #Glasgow2026 #EuropeanRenalAssociation #MedicalConference #ResearchCommunity

📢 Call for Papers | Frontiers in Cardiovascular Medicine 🫀 There is still time to submit to Cardiac Involvement in Connective Tissue Disease including Marfan and Loeys–Dietz Syndrome, a Research Topic addressing the cardiovascular manifestations and management of heritable connective tissue diseases. Connective tissue diseases, such as Marfan and Loeys–Dietz Syndrome, carry significant cardiac risk, yet critical gaps remain in surveillance, risk stratification, and long-term outcomes. This Research Topic unites basic, translational, and clinical research to advance care across the full spectrum of these conditions. We welcome research that explores genetics and mechanisms, imaging and surveillance, as well as medical, interventional, and surgical strategies. 📝 Edited by: Hicham El Masry Mayo Clinic, Phoenix, United States Fadi Shamoun - Mayo Clinic Arizona, Scottsdale, United States Stanislav Henkin - Mayo Clinic, Rochester, United States 🔗 Explore the Research Topic here: https://lnkd.in/ejwpNjUm 📅 Manuscript deadline: 13 October 2026 💡 To learn more or register your interest, contact cardiovascularmedicine@frontiersin.org or visit the Research Topic homepage. #MarfanSyndrome #LoeysDisetzSyndrome #Aortopathy #ConnectiveTissueDisease #CardiovascularMedicine

🎉 Proudly presenting the article collection "Advancements in Ischemic Retinopathies: Unraveling Molecular Mechanisms and Innovative Therapeutic Avenues" Edited by Ravirajsinh Jadeja, Pamela Martin, Dario Rusciano, and Snježana Kaštelan Ischemic retinopathies, commonly described as the "stroke of the retina," are major contributors to vision loss in diseases such as diabetic retinopathy, retinopathy of prematurity, and retinal vascular occlusion. Oxidative stress and inflammatory pathways play a pivotal role in their pathogenesis. In the ischemic retina, an excess of free radicals prompts neurodegeneration alongside glial activation and vascular injury. This detrimental cascade underscores the urgent need to delve deeper into both the condition's molecular underpinnings and its clinical manifestations. This Research Topic aims to enhance the understanding of ischemic retinopathies through the exploration of novel molecular mechanisms and therapeutic opportunities. By dissecting the roles of oxidative stress and inflammation, and by identifying new biomarkers and targets, this collection seeks to set the stage for the next generation of treatments. Enhanced knowledge here could lead to significant advancements in therapeutic strategies, improving outcomes for patients affected by these challenging conditions. 👉 Browse the collection: https://lnkd.in/ei4WPxJd Published in Frontiers in Medicine (Impact Factor 3.0, CiteScore 6.0)  medicine@frontiersin.org #retinopathy #retinopathies #retina #ophthalmology #openaccess

📢 Call for papers!  The article collection "Long COVID in Family Medicine and Primary Care Services" is open to submissions Edited by Silke Brenne, Susanne Yvette Young, and Marcia Spoelder Coordinated by Regine Mößle Despite its growing relevance, long COVID remains diagnostically and therapeutically challenging. There are currently no biomarkers or definitive laboratory tests to determine the disease, and testing for COVID-19 is less common. Hence doctors and therapists face major challenges in diagnosis. This diagnostic uncertainty, combined with variable disease trajectories and limited evidence for targeted therapies, poses considerable challenges for healthcare systems. Since general practitioners are often the first point of contact for patients, the perspective of family medicine is of particular importance for healthcare research and improved patient care. This Research Topic aims to present research on long COVID that is relevant to family medicine and primary care, with a focus on patient centred interdisciplinary care structures that include validation and psychotherapeutic support to help patients cope, adjust, and manage the psychological impact of chronic symptoms and uncertainty. We welcome manuscripts which consider the unique opportunities and challenges of care for long COVID in general practice and provide insights of interest and value to family doctors. Attention will also be paid to low-threshold services that integrate all forms of digital healthcare, better social recognition and transparent information channels. 🗓️ Manuscript submission deadline: 28 January 2027 👉 Contribute or find out more: https://lnkd.in/ep5AicJW Hosted by Frontiers in Medicine (Impact Factor 3.0, CiteScore 6.0):  medicine@frontiersin.org #longCOVID #postCOVID #postCOVIDsyndrome #COVID19 #qualityoflife #primarycare #generalpractice #openaccess

🌟 New eBook! "Uncommon or Rare Forms of Diabetes: From Diagnosis to Management" is now available for download Edited by Valeria Grancini and Andrea Mario Bolla Uncommon and rare forms of diabetes represent a complex and underexplored area within the broader field of diabetology. Unlike the well‑characterized type 1 and type 2 diabetes, these atypical forms - including monogenic, mitochondrial, cystic fibrosis–related, drug‑induced, and syndromic diabetes - pose unique diagnostic and management challenges due to their heterogeneity and low prevalence. Misdiagnosis or delayed recognition can lead to inappropriate treatment and an increased risk of long‑term complications. This Research Topic gathers the latest knowledge on the diagnosis, management, and treatment of uncommon and rare forms of diabetes, with the aim of fostering a holistic understanding of rare diabetes subtypes and promoting better clinical outcomes. 👉 Download the eBook or browse the collection: https://lnkd.in/ex-jE_wj Published in Frontiers in Medicine (Impact Factor 3.0, CiteScore 6.0)  medicine@frontiersin.org #diabetes #rarediseases #endocrinopathies #openaccess

📢 Call for papers - Frontiers in Medicine The article collection "Precision Medicine and Stakeholders: Where do we stand and how to enhance the role of involved stakeholders?" is now open to submissions! Led by Drs. Margarita-Ioanna Koufaki, Mohamed Nagy, Maha Saber-Ayad, Coen Wiegman Pharmacogenomics (PGx) holds transformative potential for modern medicine, enabling tailored treatment plans based on an individual's genetic profile. Yet despite rapid scientific progress, adoption of PGx testing in clinical practice remains limited. Barriers including low stakeholder awareness, unresolved cost-effectiveness questions, and the challenge of ensuring clinical evidence keeps pace with technological enthusiasm continue to slow implementation. This Research Topic examines the current landscape of PGx adoption through the lens of its many stakeholders—patients, clinicians, pharmacists, insurers, policymakers, and beyond. It explores the attitudes, knowledge gaps, and perceptions that shape uptake across diverse healthcare systems and cultural contexts, recognising that the path to integration looks different depending on where you are in the world. By bringing together perspectives on economic evaluation, evidence-based implementation, regulatory considerations, and awareness strategies, this collection aims to generate actionable insights that can meaningfully accelerate the responsible and equitable adoption of PGx testing globally. 🗓️ Manuscript submission deadline: 30 December 2026 👉 Contribute or find out more: https://lnkd.in/dN7EKv_V #Pharmacogenomics #Perceptions #InformationalStrategies #Stakeholders #Intentions #OpenAccess #PalliativeCare hashtag #PrecisionMedicine hashtag #Pharmacogenomics hashtag #OpenAccess